Harvard Bioscience, Inc. (HBIO) Earnings Per Share (EPS)
Harvard Bioscience, Inc. (HBIO) earnings per share history, EPS estimates, and growth trends. Track EPS in Excel with MarketXLS.
EPS (Earnings Per Share) Data
| Period | Diluted EPS (USD) |
|---|---|
| 2016-12-31 | -$0.13 |
| 2017-12-31 | -$0.02 |
| 2018-12-31 | -$0.08 |
| 2019-12-31 | -$0.24 |
| 2020-12-31 | -$0.20 |
| 2021-12-31 | -$0.01 |
| 2022-12-31 | -$0.23 |
| 2023-12-31 | -$0.08 |
| 2024-12-31 | -$0.28 |
| 2025-12-31 | -$1.28 |
How HBIO compares with sector peers
| Symbol | Company | Diluted EPS (latest fiscal year) |
|---|---|---|
| IMUX | Immunic Inc. | -$0.62 |
| ARVN | Arvinas Inc. | -$1.14 |
| NTRA | Natera Inc. | -$1.52 |
| FLGT | Fulgent Genetics Inc. | -$1.97 |
| VYGR | Voyager Therapeutics Inc. | -$2.04 |
These are five companies in the same sector as HBIO with a comparable annual diluted earnings per share. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Harvard Bioscience, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =EarningsPerShare("HBIO")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | HBIO | $6.13 | -4.07% | 0.03M |
| 3 | ||||
| 4 | ||||
| 5 |